Characterization of tree shrew telomeres and telomerase

J Genet Genomics. 2021 Jul 20;48(7):631-639. doi: 10.1016/j.jgg.2021.06.004. Epub 2021 Jun 25.

Abstract

The use of tree shrews as experimental animals for biomedical research is a new practice. Several recent studies suggest that tree shrews are suitable for studying cancers, including breast cancer, glioblastoma, lung cancer, and hepatocellular carcinoma. However, the telomeres and the telomerase of tree shrews have not been studied to date. Here, we characterize telomeres and telomerase in tree shrews. The telomere length of tree shrews is approximately 23 kb, which is longer than that of primates and shorter than that of mice, and it is extended in breast tumor tissues according to Southern blot and flow-fluorescence in situ hybridization (FISH) analyses. Tree shrew spleen, bone marrow, testis, ovary, and uterus show high telomerase activities, which are increased in breast tumor tissues by telomeric repeat amplification protocol assays. The telomere length becomes shorter, and telomerase activity decreases with age. The tree shrew TERT and TERC are more highly similar to primates than to rodents. These findings lay a solid foundation for using tree shrews to study aging and cancers.

Keywords: Breast cancer; TERC; TERT; Telomere; Tree shrews.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Telomerase*

Substances

  • Telomerase